Metabolic control during the neonatal period in phenylketonuria: associations with childhood IQ
- 8 September 2021
- journal article
- research article
- Published by Springer Nature in Pediatric Research
- Vol. 91 (4) , 874-878
Abstract
Background In phenylketonuria, treatment and subsequent lowering of phenylalanine levels usually occur within the first month of life. This study investigated whether different indicators of metabolic control during the neonatal period were associated with IQ during late childhood/early adolescence. Methods Overall phenylalanine concentration during the first month of life (total “area under the curve”), proportion of phenylalanine concentrations above upper target level (360 μmol/L) and proportion below lower target level (120 μmol/L) during this period, diagnostic phenylalanine levels, number of days until phenylalanine levels were 360 μmol/L during the first month of life negatively correlated with IQ in late childhood/early adolescence. Separately, phenylalanine concentrations during different periods within the first month of life (0–10 days, 11–20 days, 21–30 days) were negatively correlated with later IQ as well, but correlation strengths did not differ significantly. No further significant associations were found. Conclusions In phenylketonuria, achievement of target-range phenylalanine levels during the neonatal period is important for cognition later in life, also when compared to other indicators of metabolic control. Impact In phenylketonuria, it remains unclear during which age periods or developmental stages metabolic control is most important for later cognitive outcomes. Phenylalanine levels during the neonatal period were clearly and negatively related to later IQ, whereas no significant associations were observed for other indices of metabolic control. This emphasizes the relative importance of this period for cognitive development in phenylketonuria. No further distinctions were observed in strength of associations with later IQ between different indicators of metabolic control during the neonatal period. Thus, achievement of good metabolic control within 1 month after birth appears “safe” with respect to later cognitive outcomes.Keywords
This publication has 36 references indexed in Scilit:
- Correlation of age‐specific phenylalanine levels with intellectual outcome in patients with phenylketonuriaJournal of Inherited Metabolic Disease, 2011
- Neurological complications and behavioral problems in patients with phenylketonuria in a Follow-up UnitMolecular Genetics and Metabolism, 2011
- Suboptimal outcomes in patients with PKU treated early with diet alone: Revisiting the evidenceMolecular Genetics and Metabolism, 2010
- PhenylketonuriaThe Lancet, 2010
- Phenylketonuria: a 21st century perspectiveNature Reviews Endocrinology, 2010
- Developmental neurobiology of cognitive control and motivational systemsCurrent Opinion in Neurobiology, 2010
- Executive function in early-treated phenylketonuria: Profile and underlying mechanisms☆☆☆Molecular Genetics and Metabolism, 2010
- Pathogenesis of cognitive dysfunction in phenylketonuria: Review of hypotheses☆Molecular Genetics and Metabolism, 2010
- Phenylalanine blood levels and clinical outcomes in phenylketonuria: A systematic literature review and meta-analysisMolecular Genetics and Metabolism, 2007
- Frontal lobe‐dependent functions in treated phenylketonuria: Blood phenylalanine concentrations and long‐term deficits in adolescents young adultsJournal of Inherited Metabolic Disease, 2003